These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2101777)

  • 1. Potential of bifonazole for direct lethal action.
    Beggs WH
    Drugs Exp Clin Res; 1990; 16(11):543-7. PubMed ID: 2101777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifungal agents. VIII. Synthesis and antifungal activities of bipyrryl analogues of bifonazole.
    di Santo R; Massa S; Costi R; Simonetti G; Retico A; Apuzzo G; Troccoli F
    Farmaco; 1994 Apr; 49(4):229-36. PubMed ID: 8049002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microscopic studies of Candida albicans and Torulopsis glabrata after in vitro treatment with bifonazole. Light and scanning electron microscopy.
    Barug D; Samson RA; Kerkenaar A
    Arzneimittelforschung; 1983; 33(4):528-37. PubMed ID: 6347209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of the antifungal effect of bifonazole on Torulopsis glabrata and Candida albicans under various in vitro test conditions.
    Barug D; Bastiaanse HB
    Arzneimittelforschung; 1983; 33(4):524-8. PubMed ID: 6409128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro antifungal activity of sertaconazole, bifonazole, ketoconazole, and miconazole against yeasts of the Candida genus.
    Carrilo-Muñoz AJ; Tur C; Torres J
    J Antimicrob Chemother; 1996 Apr; 37(4):815-9. PubMed ID: 8722548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fungicidal activity of tioconazole in relation to growth phase of Candida albicans and Candida parapsilosis.
    Beggs WH
    Antimicrob Agents Chemother; 1984 Nov; 26(5):699-701. PubMed ID: 6097174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Researches on antibacterial and antifungal agents, XII: Analogues of bifonazole with two imidazole moieties and related azoles.
    Stefancich G; Silvestri R; Panico S; Artico M; Simonetti N
    Arch Pharm (Weinheim); 1990 May; 323(5):273-80. PubMed ID: 2200385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro studies of a new imidazole antimycotic, bifonazole, in comparison with clotrimazole and miconazole.
    Yamaguchi H; Hiratani T; Plempel M
    Arzneimittelforschung; 1983; 33(4):546-51. PubMed ID: 6683531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifungal agents. 7. Dichlorophenylpyrrylimidazolylmethane derivatives: synthesis and antifungal activities.
    Massa S; Mai A; Ragno R; Porretta GC; Retico A; Simonetti G; Artico M
    Farmaco; 1994 Jan; 49(1):51-5. PubMed ID: 8185750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents.
    Choukri F; Benderdouche M; Sednaoui P
    J Mycol Med; 2014 Dec; 24(4):303-7. PubMed ID: 25442913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth phase in relation to the lethal action of tamoxifen on Candida albicans.
    Beggs WH
    Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):115-8. PubMed ID: 7620832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of bifonazole (BAY H 4502) with clotrimazole in vitro.
    Shadomy S; Dixon DM; May R
    Sabouraudia; 1982 Dec; 20(4):313-23. PubMed ID: 7157107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal agents. 10. Synthesis and antifungal activities of aryl-(1H-imidazol-1-yl)-(isoquinolin-1-yl) methane derivatives.
    Silvestri R; Pagnozzi E; Troccoli F; Stefancich G; Massa S; Apuzzo G; Perazzi ME; Artico M; Simonetti G
    Farmaco; 1995 Apr; 50(4):227-38. PubMed ID: 7669167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The action of miconazole of the growth of Candida albicans.
    Van Den Bossche H; Willemsens G; Van Cutsem JM
    Sabouraudia; 1975 Mar; 13 Pt 1():63-73. PubMed ID: 1091999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microscopic studies of Candida albicans and Torulopsis glabrata after in vitro treatment with bifonazole. Freeze fracture electron microscopy.
    Barug D; de Groot C
    Arzneimittelforschung; 1983; 33(4):538-45. PubMed ID: 6347210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro antifungal activity of sertaconazole, econazole, and bifonazole against Candida spp.
    Carrillo-Muñoz AJ; Torres-Rodriguez JM
    J Antimicrob Chemother; 1995 Oct; 36(4):713-6. PubMed ID: 8591947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial activity of a new derivative: N-(4-chlorobenzyl)-2-(1H-imidazol-1-ylmethyl)benzenamine.
    Panico S; Villa A; Simonetti N; Porretta GC; Scalzo M
    Drugs Exp Clin Res; 1990; 16(4):181-6. PubMed ID: 2076654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of pH on ketoconazole activity against Candida parapsilosis and Candida albicans.
    Beggs WH
    Res Commun Chem Pathol Pharmacol; 1982 Sep; 37(3):495-8. PubMed ID: 6294764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal agents. 9. 3-Aryl-4-[alpha-(1H-imidazol-1-yl)arylmethyl]pyrroles: a new class of potent anti-Candida agents.
    Artico M; Di Santo R; Costi R; Massa S; Retico A; Artico M; Apuzzo G; Simonetti G; Strippoli V
    J Med Chem; 1995 Oct; 38(21):4223-33. PubMed ID: 7473549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal agents. VI. In vitro antifungal activities of halobenzoyl esters of cis- and trans-[2-(1,1'-biphenyl-4-yl)-2-(1H-imidazol-1-ylmethyl)-1,3- dioxolan-4-yl]carbinols.
    Stefancich G; Silvestri R; Pagnozzi E; Artico M; Retico A; Apuzzo G; Simonetti N
    Farmaco; 1993 Aug; 48(8):1103-12. PubMed ID: 8216672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.